Consensus American Well Corporation

Stocks

AMWL

US03044L2043

Healthcare Facilities & Services

Market Closed - NYSE 16:00:02 2026-08-24 EDT			5-day change	1st Jan Change
11.92 ^USD	+0.17%		-3.40%	+142.77%

08-13	Truist Adjusts American Well's Price Target to $12 From $7.50, Keeps Hold Rating	MT
08-04	American Well Corporation, Q2 2026 Earnings Call, Aug 04, 2026

Evolution of the Average Target: American Well Corporation

Evolution of the Target Price: American Well Corporation

Changes in Analyst Recommendations: American Well Corporation

c6488fdeb6c26c02849700ac89832a7._rhZD8-BO6MOmg2MSRgJSOsN2_9TdLyPZ0foSDn6S7A.nPE_XYLSb-JIqWTVEXlwHaRPjLIwIPT9ERKPcQ3PLPKu62xfjPNv4TiqTA~0b31abc87ad29bf79cdbf38d33c84a98

Analysts' recommendations: American Well Corporation

08-13	Truist Adjusts American Well's Price Target to $12 From $7.50, Keeps Hold Rating	MT
11-13	Truist Removes $7.50 Price Target on American Well, Cites Share Volatility, Low Share Price; Hold Rating Kept	MT
25-04-10	Truist Cuts Price Target on American Well to $7.50 From $12, Keeps Hold Rating	MT
25-02-14	Truist Securities Adjusts Price Target on American Well to $12 From $10, Keeps Hold Rating	MT
25-01-13	Wells Fargo Upgrades American Well to Overweight From Equalweight, Price Target is $15	MT
24-12-17	Morgan Stanley Adjusts Price Target on American Well to $10.50 From $20	MT
24-05-23	UBS Adjusts American Well Price Target to $0.60 From $1.50, Maintains Neutral Rating	MT
24-04-15	Morgan Stanley Adjusts American Well's Price Target to $1 From $1.75, Keeps Equalweight Rating	MT
23-11-08	UBS Adjusts American Well Price Target to $1.30 From $2.60, Maintains Neutral Rating	MT
23-08-04	UBS Adjusts Price Target on American Well to $2.60 From $2.80, Maintains Neutral Rating	MT
23-08-03	Morgan Stanley Downgrades American Well to Equalweight From Overweight, Halves PT to $2.50 From $5, Cites Weaker-Than-Expected Growth	MT
23-05-04	Credit Suisse Trims American Well's Price Target to $3.50 From $4 After Lower-Than-Expected Q1 Results, Keeps Neutral Rating	MT
23-03-23	TD Cowen Downgrades American Well to Market Perform From Outperform, Adjusts Price Target to $2.50 From $5	MT
23-03-13	Morgan Stanley Adjusts Price Target on American Well to $5 From $6, Maintains Overweight Rating	MT
23-02-28	UBS Adjusts American Well Price Target to $3.10 From $4.20, Maintains Neutral Rating	MT
23-02-27	Piper Sandler Downgrades American Well to Neutral From Overweight, Adjusts Price Target to $3.50 From $5	MT
23-02-23	Credit Suisse Trims American Well's Price Target to $4 From $5 on Lower-Than-Expected 2023 Outlook, Keeps Neutral Rating	MT
23-01-06	Morgan Stanley Cuts Price Target on American Well to $6 From $7, Reiterates Overweight Rating	MT
23-01-04	BofA Securities Upgrades American Well to Buy From Neutral, Price Target is $4.20	MT
22-09-07	Truist Securities Starts American Well at Hold With $5 Price Target	MT
22-09-07	Piper Sandler Adjusts American Well's Price Target to $5 From $6, Reiterates Overweight Rating	MT
22-08-08	UBS Adjusts American Well Price Target to $4.20 From $3.25, Maintains Neutral Rating	MT
22-07-01	Berenberg Bank Terminates Coverage of 85 Companies in Consumer Discretionary, Healthcare, Industrial Tech, REIT, Software and IT Services Sectors	MT
22-06-23	Piper Sandler Adjusts American Well's Price Target to $6 From $5, Maintains Overweight Rating	MT
22-05-26	Goldman Sachs Adjusts Price Target for American Well to $4.50 From $5, Maintains Neutral Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	AMERICAN WELL CORPORATION					+7.38%
	HIMS & HERS HEALTH, INC.					+0.49%
	OMADA HEALTH, INC.					+17.32%
	TELADOC HEALTH, INC.					+24.79%
	Average					+12.49%
	Weighted average by Cap.					+5.81%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

11.92USD

Average target price

12.80USD

Spread / Average Target

+7.38%

High Price Target

16.00USD

Spread / Highest target

+34.23%

Low Price Target

11.00USD

Spread / Lowest Target

-7.72%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Truist Securities
Wells Fargo Securities
Morgan Stanley
UBS
Credit Suisse
TD Cowen
Piper Sandler
BofA Securities
Goldman Sachs
Guggenheim
Jefferies & Co.
Berenberg Bank
Cowen
Cantor Fitzgerald
KeyBanc Capital Markets
Needham & Co.